Genbioca Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 8 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 56.39%
(FY 2023)
- Profit 38.94%
(FY 2023)
- Ebitda 124.34%
(FY 2023)
- Net Worth 87.11%
(FY 2023)
- Total Assets 11.13%
(FY 2023)
About Genbioca Sciences
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rupa Kandukuri, Venkata Kandukuri, and Shashikala Gaddi serve as directors at the Company.
- CIN/LLPIN
U74999MH2016PTC280136
- Company No.
280136
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Apr 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Genbioca Sciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rupa Kandukuri  | Director | 21-Apr-2016 | Current |
| Venkata Kandukuri | Director | 31-May-2021 | Current |
Shashikala Gaddi  | Director | 15-Dec-2017 | Current |
Financial Performance and Corporate Structure Insights of Genbioca Sciences.
Genbioca Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 56.39% increase. The company also saw a substantial improvement in profitability, with a 38.94% increase in profit. The company's net worth Soared by an impressive increase of 87.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Genbioca Sciences?
In 2023, Genbioca Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Genbioca Sciences?
Unlock and access historical data on people associated with Genbioca Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genbioca Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genbioca Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
